DFE Pharma

This year CPHI Europe opens its doors in Milan at Fiera Milano. From 6th to 8th October you can have a...

Abstract Lactose (LA), the primary carrier in dry powder inhalers (DPIs), often exhibits excessive drug adhesion, which impairs aerosolization. In...

Abstract The stability of moisture-sensitive active pharmaceutical ingredients (APIs) in solid dosage forms is a key determinant of product quality...

Abstract In vitro compatibility assessments are a valuable tool for the early identification of potential drug–vehicle interactions. To standardize such evaluations,...

An experienced international HR leader, Alawi joins DFE Pharma’s Leadership Team to support the company’s people-centric, high-performance culture. Goch, Germany...

Abstract To facilitate the development of protein depots for sustained delivery, this study optimized spray-dried formulations of a model antibody...

Abstract The dynamic and transitory nature of the distal small intestine makes targeted drug delivery to this region particularly challenging....

This recognition places DFE Pharma among the top 5% of companies assessed worldwide and highlights continued progress in environmental action,...

DFE Pharma,  announced the launch of its Continuous Manufacturing (CM) platform, designed to support pharmaceutical companies in formulation development, optimization,...

Abstract Purpose To overcome the strong inter-particulate interactions between the drug and carrier in dry powder inhalers (DPIs), an amorphous...